Lasting Gammaproteobacteria profile changes characterized hematological cancer patients who developed oral mucositis following conditioning therapy
Year: 2020
Type: article
Study design: Observational Study
Abstract: Background Oral mucositis (OM) is a common side effect of conditioning therapy implemented before hematopoietic stem cell transplantation (HSCT). The role of oral microbiome in OM is not fully elucidated.Objective To determine oral microbiome profile changes post-conditioning in HSCT patients who developed moderate OM, or mild to no OM.Design Patient groups were: Muc0-1 with OM-score = 0–1 (43 paired samples) and Muc2 with WHO OM-score = 2 (36 paired samples). Bacterial DNA was isolated from oral samples (saliva, swabs of buccal mucosa, tongue, and supragingival plaque) at pre-conditioning (T0), post-conditioning mucositis onset (TMuc), and one-year post-conditioning (TYear). 16S-rRNA gene next-generation sequencing was used to determine the relative abundance (RA) of >700 oral species. Alpha-diversity, beta-diversity and linear discriminant analyses (LDA) were performed Muc2 versus Muc0-1.Results Muc2 oral microbiome alpha- and beta-diversity differed between T0 and TMuc. Muc2 alpha-diversity and Muc0-1 beta-diversity did not differ between T0 and TYear. T0 to TMuc LDA scores were significant in Muc2 for Gammaproteobacteria. For Muc2 patients, the average RA decreased for Haemophilus parainfluenza, a species known as mucosal surfaces protector, but increased for Escherichia-Shigella genera.Conclusions Post-conditioning OM might contribute to long-term oral microbiome changes affecting Gammaproteobacteria, in HSCT patients.
Source: Journal of Oral Microbiology
Institutions: Carolinas Medical Center, University of Gothenburg
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,428
Funder: Atrium Health Foundation
OpenAlex ID: W3024192141
